Mindfulness Meditation vs Escitalopram for Treatment of Anxiety Disorders JAMA Network Open October 1, 2024 Hiroe Hu, M. Mete, Neil K Rustgi et al. This secondary analysis of a randomized clinical trial assesses patient-reported anxiety, depression, and quality of life among patients receiving mindfulness-based stress reduction vs escitalopram for the treatment of anxiety disorders. DOI: 10.1001/jamanetworkopen.2024.38453 (opens in new tab) Full text (opens in new tab)